Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
Amanda Fortes
Francisco
;
Michael D
Lewis
;
Shiromani
Jayawardhana
;
Martin C
Taylor
;
Eric
Chatelain
;
John M
Kelly
;
(2015)
Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs".
Antimicrobial agents and chemotherapy, 59 (12).
7925-.
ISSN 0066-4804
DOI: 10.1128/AAC.02022-15
Item Type | Article |
---|---|
ISI | 368337300111 |
Date Deposited | 01 Dec 2015 20:06 |
Explore Further
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649144 (OA Location)
- 10.1128/AAC.02022-15 (DOI)
- 26578702 (PubMed)
ORCID: https://orcid.org/0000-0002-3475-8130
ORCID: https://orcid.org/0000-0001-9540-3280
ORCID: https://orcid.org/0000-0003-4147-0693
ORCID: https://orcid.org/0000-0003-4305-5258